Nearly 80% of patients didn’t follow washout protocol, raising risk of misdiagnosis
Studies of three investigational therapies test targeting of mechanistic pathways
Lower-sodium product is latest advance in an active therapeutic area
New drug for adults with OSA or narcolepsy expected to launch soon
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement